Serology Testing Market: By Test Type, By Application, By Technology, By End Users, and Geography.

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Serology Testing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Test Type (Primary Serological Tests, Secondary Serological Tests, Tertiary Binding Tests), By Application (Rotavirus Infections, Hepatitis, HIV, Endotoxins, Therapeutic Drug Monitoring, Immunoglobin G, and Others), By Technology (ELISA, NAT, CLIA/CMIA and Others), By End Users (Hospitals, Diagnostic Laboratories, Blood Banks, Academic and Research Institutes, Others), and Region.

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Serology Testing Market size was valued at US$ 4,305.0 million in 2022 and is expected to grow at a CAGR of 14.0% from 2023 to 2029. The serological testing is used to diagnose and analyse various types disease causing viruses like rota virus infection, HIV, endotoxins and other infectious disease causing viruses. The increasing incidence of COVID cases and increasing healthcare expenditure across the globe is expected to drive the growth of serology testing market over the forecasted years. In addition increasing investments in research and developments for COVID analysis kits and the government initiatives supporting the research of this segment is expected to boost the market growth at an significant rate over the forecasted period. Furthermore, rising number of product launches and approval of serology testing kits are expected to fuel the market growth. However, shortage of serology testing kits, strict government regulations regarding the safety and high cost of serology testing kits are expected to hinder the market growth over the forecasted period. Moreover, increasing prevalence of diseases like HIV/AIDS, tuberculosis, hepatitis across the globe, increasing demand for ELISA test across the globe and increasing incidence of tuberculosis in geriatric population is expected to provide opportunities to the key market players in the growth of serology testing market over the forecasted period. Geographically, Asia Pacific region is expected to have a significant growth over the forecasted period due to the increasing awareness about the disease and high rate of infectious disease incidence in countries like India and China and rising per capita healthcare expenditure. The Europe region held the major market share in 2022 and is expected to dominate the global serology testing market in the forecasted years.

Serology Testing Market Key Developments:

  • In April 2020, Accelerate Diagnostics and Biocheck collaborated to distribute SARS-COV-2 Antibody tests and MS-FAST Chemiluminescence Immunoassay Analyzer.
  • In March 2020, Chembio Diagnostic Systems Inc launched their product ‘DPP Covid-19 serological test kit.

summary download arrow Download Free Sample

Serology Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

14%

Largest Market

Europe

Fastest Growing Market

North America

Serology Testing Market Dynamics

Serology testing market is expected to grow over the forecasted period owing to the increasing prevalence of infectious disease across the globe. In addition, increasing investments in research and developments for COVID analysis kits and the government initiatives supporting the research of this segment is expected to boost the market growth at an significant rate over the forecasted period. Availability of well-developed healthcare infrastructure in emerging regions such as Europe, Asia Pacific is expected to fuel the market growth over the forecasted period. Furthermore, increase in research and product launches by the key market players is expected to fuel the market growth.

Serology Testing Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2022

US$ 4,305.0 million

Market CAGR

14%

By Test Type

  • Primary Serological Tests
  • Secondary Serological Tests
  • Tertiary Binding Tests

By Application

  • Rotavirus Infections
  • Hepatitis
  • HIV
  • Endotoxins
  • Therapeutic Drug Monitoring
  • Immunoglobin G
  • Others

By Technology

  • ELISA
  • NAT
  • CLIA/CMIA
  • Others

By End User

  • Hospital and Clinics
  • Diagnostic Laboratories
  • Others

By Region

  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA

Key Features of the Report

  • The serology testing market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy
LOCATION

Geography

geography

Frequently Asked Questions

Serology Testing market was valued at US$ 4,305.0 million in 2022, growing at a 14.0% CAGR from 2023 to 2029

Increasing prevalence of infectious diseases, rising investments in research and developments are expected to drive the growth of serology testing market over the forecasted period.

The leading players in the global Serology Testing market are F. Hoffmann La-Roche Ltd, Thermo Fisher Scientific, Inc., Beckman Coulter, Inc., ELI Tech Group, Becton, Dickinson and Company (BD), Abbott, Randox Laboratories Ltd., Quest Diagnostics, Serological Research Institute., Creative Diagnostics

Europe market is expected to hold major market share in the forecasted period. Followed by Asia Pacific region and North America region.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Serology Testing Market Introduction 
2.1.Global Serology Testing Market  - Taxonomy
2.2.Global Serology Testing Market  - Definitions
2.2.1.Test Type
2.2.2.Application 
2.2.3.Technology
2.2.4.End User
2.2.5.Region
3.Global Serology Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Serology Testing Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Serology Testing Market  By Test Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Primary Serological Tests
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Secondary Serological Tests
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Tertiary Binding Tests
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Serology Testing Market  By Application , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Rotavirus Infections
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Hepatitis
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. HIV
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Endotoxins
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Therapeutic Drug Monitoring
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Immunoglobin G
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Others
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
7.Global Serology Testing Market  By Technology, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. ELISA
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. NAT
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. CLIA/CMIA
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Others
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Serology Testing Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Hospital and Clinics
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Diagnostic Laboratories
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Others
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9.Global Serology Testing Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Serology Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Primary Serological Tests
10.1.2.Secondary Serological Tests
10.1.3.Tertiary Binding Tests
10.2.  Application  Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Rotavirus Infections
10.2.2.Hepatitis
10.2.3.HIV
10.2.4.Endotoxins
10.2.5.Therapeutic Drug Monitoring
10.2.6.Immunoglobin G
10.2.7.Others
10.3.  Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.ELISA
10.3.2.NAT
10.3.3.CLIA/CMIA
10.3.4.Others
10.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospital and Clinics
10.4.2.Diagnostic Laboratories
10.4.3.Others
10.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Serology Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Primary Serological Tests
11.1.2.Secondary Serological Tests
11.1.3.Tertiary Binding Tests
11.2.  Application  Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Rotavirus Infections
11.2.2.Hepatitis
11.2.3.HIV
11.2.4.Endotoxins
11.2.5.Therapeutic Drug Monitoring
11.2.6.Immunoglobin G
11.2.7.Others
11.3.  Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.ELISA
11.3.2.NAT
11.3.3.CLIA/CMIA
11.3.4.Others
11.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospital and Clinics
11.4.2.Diagnostic Laboratories
11.4.3.Others
11.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12.Asia Pacific (APAC) Serology Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Primary Serological Tests
12.1.2.Secondary Serological Tests
12.1.3.Tertiary Binding Tests
12.2.  Application  Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Rotavirus Infections
12.2.2.Hepatitis
12.2.3.HIV
12.2.4.Endotoxins
12.2.5.Therapeutic Drug Monitoring
12.2.6.Immunoglobin G
12.2.7.Others
12.3.  Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.ELISA
12.3.2.NAT
12.3.3.CLIA/CMIA
12.3.4.Others
12.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospital and Clinics
12.4.2.Diagnostic Laboratories
12.4.3.Others
12.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Serology Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Primary Serological Tests
13.1.2.Secondary Serological Tests
13.1.3.Tertiary Binding Tests
13.2.  Application  Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Rotavirus Infections
13.2.2.Hepatitis
13.2.3.HIV
13.2.4.Endotoxins
13.2.5.Therapeutic Drug Monitoring
13.2.6.Immunoglobin G
13.2.7.Others
13.3.  Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.ELISA
13.3.2.NAT
13.3.3.CLIA/CMIA
13.3.4.Others
13.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospital and Clinics
13.4.2.Diagnostic Laboratories
13.4.3.Others
13.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Serology Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
14.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Primary Serological Tests
14.1.2.Secondary Serological Tests
14.1.3.Tertiary Binding Tests
14.2.  Application  Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Rotavirus Infections
14.2.2.Hepatitis
14.2.3.HIV
14.2.4.Endotoxins
14.2.5.Therapeutic Drug Monitoring
14.2.6.Immunoglobin G
14.2.7.Others
14.3.  Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.ELISA
14.3.2.NAT
14.3.3.CLIA/CMIA
14.3.4.Others
14.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospital and Clinics
14.4.2.Diagnostic Laboratories
14.4.3.Others
14.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.F. Hoffmann La-Roche Ltd
15.2.2.Thermo Fisher Scientific, Inc.
15.2.3.Beckman Coulter, Inc.
15.2.4.ELI Tech Group
15.2.5.Becton, Dickinson and Company (BD)
15.2.6.Abbott
15.2.7.Randox Laboratories Ltd.
15.2.8.Quest Diagnostics
15.2.9.Serological Research Institute.
15.2.10.Creative Diagnostics
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • F. Hoffmann La-Roche Ltd
  • Thermo Fisher Scientific, Inc.
  • Beckman Coulter, Inc.
  • ELI Tech Group
  • Becton, Dickinson and Company (BD)
  • Abbott
  • Randox Laboratories Ltd.
  • Quest Diagnostics
  • Serological Research Institute.
  • Creative Diagnostics

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market